Please confirm that you would like to log out of Medscape.
If you log out, you will be required to enter your username and password the next time you visit.
Log outCancel
IDF 2019Docs Debate Insulin vs GLP-1 Agonist as First Injectable for T2D Two experts debated the statement, which arose from the ADA/EASD type 2 diabetes joint consensus statement, that GLP-1 agonists are preferred to insulin as the first-line injectable medication.
Hype or Hope: Will the 3Cs of Diabetes Tech Revolutionize Care?Some believe technology will transform diabetes care in the future, but there is still a long way to go until it enters mainstream
clinical practice globally; so far, only a minority of patients use it.
Dealing With Diabetes in Disaster Zones: Planning Is VitalHow to help people living with diabetes caught up in natural or human-caused disasters was a central focus of the IDF Congress
this year; there is much work still to be done, attendees heard.
